Genetec Technology Berhad (KLSE:GENETEC)

Genetec Technology Berhad Statistics

Total Valuation

KLSE:GENETEC has a market cap or net worth of MYR 235.80 million. The enterprise value is 275.14 million.

Market Cap	235.80M
Enterprise Value	275.14M

Important Dates

The last earnings date was Tuesday, November 25, 2025.

Earnings Date	Nov 25, 2025
Ex-Dividend Date	n/a

Share Statistics

KLSE:GENETEC has 773.12 million shares outstanding. The number of shares has increased by 1.88% in one year.

Current Share Class	773.12M
Shares Outstanding	773.12M
Shares Change (YoY)	+1.88%
Shares Change (QoQ)	-0.96%
Owned by Insiders (%)	20.69%
Owned by Institutions (%)	26.29%
Float	568.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	7.63
PS Ratio	1.09
PB Ratio	0.60
P/TBV Ratio	0.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.51
EV / Sales	1.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.25

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.22.

Current Ratio	2.92
Quick Ratio	2.80
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-0.69
Interest Coverage	-46.84

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-17.55%
Revenue Per Employee	628,472
Profits Per Employee	-227,345
Employee Count	345
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-371,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.60% in the last 52 weeks. The beta is -0.26, so KLSE:GENETEC's price volatility has been lower than the market average.

Beta (5Y)	-0.26
52-Week Price Change	-75.60%
50-Day Moving Average	0.47
200-Day Moving Average	0.82
Relative Strength Index (RSI)	30.33
Average Volume (20 Days)	20,575,925

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KLSE:GENETEC had revenue of MYR 216.82 million and -78.43 million in losses. Loss per share was -0.10.

Revenue	216.82M
Gross Profit	-32.68M
Operating Income	-68.62M
Pretax Income	-71.77M
Net Income	-78.43M
EBITDA	-64.74M
EBIT	-68.62M
Loss Per Share	-0.10

Balance Sheet

The company has 45.11 million in cash and 84.44 million in debt, giving a net cash position of -39.33 million or -0.05 per share.

Cash & Cash Equivalents	45.11M
Total Debt	84.44M
Net Cash	-39.33M
Net Cash Per Share	-0.05
Equity (Book Value)	390.09M
Book Value Per Share	0.50
Working Capital	252.24M

Cash Flow

In the last 12 months, operating cash flow was -97.78 million and capital expenditures -24.68 million, giving a free cash flow of -122.46 million.

Operating Cash Flow	-97.78M
Capital Expenditures	-24.68M
Free Cash Flow	-122.46M
FCF Per Share	-0.16

Margins

Gross margin is -15.07%, with operating and profit margins of -31.65% and -36.17%.

Gross Margin	-15.07%
Operating Margin	-31.65%
Pretax Margin	-33.10%
Profit Margin	-36.17%
EBITDA Margin	-29.86%
EBIT Margin	-31.65%
FCF Margin	n/a

Dividends & Yields

KLSE:GENETEC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-1.88%
Shareholder Yield	-1.88%
Earnings Yield	-33.26%
FCF Yield	-51.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 7, 2022. It was a forward split with a ratio of 13.

Last Split Date	Jan 7, 2022
Split Type	Forward
Split Ratio	13

Scores

KLSE:GENETEC has an Altman Z-Score of 4.42.

Altman Z-Score	4.42
Piotroski F-Score	n/a